Devonian Health Group Net Income
| DVHGF Stock | USD 4.27 0.00 0.00% |
As of the 20th of February, Devonian Health shows the Standard Deviation of 1020.77, mean deviation of 347.25, and Variance of 1041973.18. Devonian Health Group technical analysis allows you to utilize historical prices and volume patterns in order to determine a pattern that computes the direction of the firm's future prices. Put another way, you can use this information to find out if the firm will indeed mirror its model of historical prices and volume momentum, or the prices will eventually revert. We were able to analyze and collect data for eleven technical drivers for Devonian Health Group, which can be compared to its peers. Please confirm Devonian Health Group coefficient of variation, as well as the relationship between the total risk alpha and skewness to decide if Devonian Health Group is priced favorably, providing market reflects its regular price of 4.27 per share. Given that Devonian Health has variance of 1041973.18, we urge you to verify Devonian Health Group's prevailing market performance to make sure the company can sustain itself at a future point.
Devonian Health's financial statements offer valuable quarterly and annual insights to potential investors, highlighting the company's current and historical financial position, overall management performance, and changes in financial standing over time. Key fundamentals influencing Devonian Health's valuation are provided below:Devonian Health Group does not presently have any fundamental signals for analysis. This module does not cover all equities due to inconsistencies in global equity categorizations. Continue to Equity Screeners to view more equity screening tools. Devonian |
Devonian Health 'What if' Analysis
In the world of financial modeling, what-if analysis is part of sensitivity analysis performed to test how changes in assumptions impact individual outputs in a model. When applied to Devonian Health's otc stock what-if analysis refers to the analyzing how the change in your past investing horizon will affect the profitability against the current market value of Devonian Health.
| 11/22/2025 |
| 02/20/2026 |
If you would invest 0.00 in Devonian Health on November 22, 2025 and sell it all today you would earn a total of 0.00 from holding Devonian Health Group or generate 0.0% return on investment in Devonian Health over 90 days. Devonian Health is related to or competes with Hookipa Pharma, and ImmunoCellular Therapeutics. Devonian Health Group Inc. engages in the development of botanical drugs More
Devonian Health Upside/Downside Indicators
Understanding different market momentum indicators often help investors to time their next move. Potential upside and downside technical ratios enable traders to measure Devonian Health's otc stock current market value against overall market sentiment and can be a good tool during both bulling and bearish trends. Here we outline some of the essential indicators to assess Devonian Health Group upside and downside potential and time the market with a certain degree of confidence.
| Information Ratio | 0.1723 | |||
| Maximum Drawdown | 6003.96 |
Devonian Health Market Risk Indicators
Today, many novice investors tend to focus exclusively on investment returns with little concern for Devonian Health's investment risk. Other traders do consider volatility but use just one or two very conventional indicators such as Devonian Health's standard deviation. In reality, there are many statistical measures that can use Devonian Health historical prices to predict the future Devonian Health's volatility.| Risk Adjusted Performance | 0.1421 | |||
| Jensen Alpha | 170.88 | |||
| Total Risk Alpha | 104.63 | |||
| Treynor Ratio | 1.85 |
Devonian Health February 20, 2026 Technical Indicators
| Cycle Indicators | ||
| Math Operators | ||
| Math Transform | ||
| Momentum Indicators | ||
| Overlap Studies | ||
| Pattern Recognition | ||
| Price Transform | ||
| Statistic Functions | ||
| Volatility Indicators | ||
| Volume Indicators |
| Risk Adjusted Performance | 0.1421 | |||
| Market Risk Adjusted Performance | 1.86 | |||
| Mean Deviation | 347.25 | |||
| Coefficient Of Variation | 580.05 | |||
| Standard Deviation | 1020.77 | |||
| Variance | 1041973.18 | |||
| Information Ratio | 0.1723 | |||
| Jensen Alpha | 170.88 | |||
| Total Risk Alpha | 104.63 | |||
| Treynor Ratio | 1.85 | |||
| Maximum Drawdown | 6003.96 | |||
| Skewness | 5.61 | |||
| Kurtosis | 30.36 |
Devonian Health Group Backtested Returns
Devonian Health is out of control given 3 months investment horizon. Devonian Health Group secures Sharpe Ratio (or Efficiency) of 0.16, which denotes the company had a 0.16 % return per unit of risk over the last 3 months. We were able to analyze and collect data for seventeen different technical indicators, which can help you to evaluate if expected returns of 29.56% are justified by taking the suggested risk. Use Devonian Health Mean Deviation of 347.25, variance of 1041973.18, and Standard Deviation of 1020.77 to evaluate company specific risk that cannot be diversified away. Devonian Health holds a performance score of 12 on a scale of zero to a hundred. The firm shows a Beta (market volatility) of 95.0, which means a somewhat significant risk relative to the market. As the market goes up, the company is expected to outperform it. However, if the market returns are negative, Devonian Health will likely underperform. Use Devonian Health information ratio, and the relationship between the coefficient of variation and skewness , to analyze future returns on Devonian Health.
Auto-correlation | -0.03 |
Very weak reverse predictability
Devonian Health Group has very weak reverse predictability. Overlapping area represents the amount of predictability between Devonian Health time series from 22nd of November 2025 to 6th of January 2026 and 6th of January 2026 to 20th of February 2026. The more autocorrelation exist between current time interval and its lagged values, the more accurately you can make projection about the future pattern of Devonian Health Group price movement. The serial correlation of -0.03 indicates that only 3.0% of current Devonian Health price fluctuation can be explain by its past prices.
| Correlation Coefficient | -0.03 | |
| Spearman Rank Test | 0.96 | |
| Residual Average | 0.0 | |
| Price Variance | 0.57 |
Because income is reported on the Income Statement of a company and is measured in dollars some investors prefer to use Profit Margin, which measures income as a percentage of sales.
| Competition |
Based on the recorded statements, Devonian Health Group reported net income of (3.45 Million). This is 101.01% lower than that of the Healthcare sector and 104.92% lower than that of the Biotechnology industry. The net income for all United States stocks is 100.6% higher than that of the company.
Devonian Net Income Peer Comparison
Stock peer comparison is one of the most widely used and accepted methods of equity analyses. It analyses Devonian Health's direct or indirect competition against its Net Income to detect undervalued stocks with similar characteristics or determine the otc stocks which would be a good addition to a portfolio. Peer analysis of Devonian Health could also be used in its relative valuation, which is a method of valuing Devonian Health by comparing valuation metrics of similar companies.Devonian Health is currently under evaluation in net income category among its peers.
Devonian Fundamentals
| Return On Equity | -0.33 | |||
| Return On Asset | -0.12 | |||
| Profit Margin | (1.67) % | |||
| Operating Margin | (1.48) % | |||
| Current Valuation | 42.9 M | |||
| Shares Outstanding | 134.69 M | |||
| Shares Owned By Insiders | 7.81 % | |||
| Price To Book | 2.75 X | |||
| Price To Sales | 19.73 X | |||
| Revenue | 2.31 M | |||
| Gross Profit | 561.01 K | |||
| EBITDA | (1.65 M) | |||
| Net Income | (3.45 M) | |||
| Cash And Equivalents | 9.49 M | |||
| Cash Per Share | 0.07 X | |||
| Total Debt | 4.26 M | |||
| Debt To Equity | 0.31 % | |||
| Current Ratio | 9.07 X | |||
| Book Value Per Share | 0.12 X | |||
| Cash Flow From Operations | (2.87 M) | |||
| Beta | 1.22 | |||
| Market Capitalization | 36.79 M | |||
| Total Asset | 21.59 M | |||
| Z Score | 4.8 | |||
| Net Asset | 21.59 M |
About Devonian Health Fundamental Analysis
The Macroaxis Fundamental Analysis modules help investors analyze Devonian Health Group's financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of Devonian Health using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of Devonian Health Group based on its fundamental data. In general, a quantitative approach, as applied to this otc stock, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.
Please read more on our fundamental analysis page.
Currently Active Assets on Macroaxis
| FSLY | Fastly Class A | |
| MOB | Mobilicom Limited American | |
| CMG | Chipotle Mexican Grill | |
| CSAN | Cosan SA ADR | |
| RKT | Rocket Companies |
Other Information on Investing in Devonian OTC Stock
Devonian Health financial ratios help investors to determine whether Devonian OTC Stock is cheap or expensive when compared to a particular measure, such as profits or enterprise value. In other words, they help investors to determine the cost of investment in Devonian with respect to the benefits of owning Devonian Health security.